Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amandeep Salhotra

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|March 12, 2026
Overcoming resistance to immune checkpoint inhibitor therapy in acute myeloid leukemiaVaibhav Agrawal, Amandeep Salhotra
Cancer Treatment and Research|October 9, 2021
Acute Promyelocytic Leukemia: Update on Risk Stratification and Treatment PracticesAmandeep Salhotra, Matthew Mei
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 22, 2014
JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein ThrombosisAmandeep Salhotra, Thein H Oo
Frontiers in Oncology|March 4, 2022
Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant RelapseAmandeep Salhotra, Anthony Selwyn Stein
Cureus|January 10, 2022
Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic LeukemiaColton Ladbury, Amandeep Salhotra, Savita Dandapani
Journal of Intensive Care Medicine|August 7, 2024
Graft Versus Host Disease: Management Issues in the Intensive Care UnitAmandeep Salhotra, Dat Ngo, Waasil Kareem
Frontiers in Oncology|September 13, 2023
Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantationAmandeep Salhotra, Shan Yuan, Haris Ali
Expert Review of Clinical Immunology|March 11, 2020
Ruxolitinib for the treatment of graft-versus-host diseaseHaris Ali, Amandeep Salhotra, Badri Modi, et al.
Acta Haematologica|September 14, 2023
Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia PatientsJose Tinajero, Dat Ngo, Amandeep Salhotra, et al.
Leukemia & Lymphoma|September 27, 2013
Plerixafor to the rescue: boosting peripheral blood stem cell mobilization in patients previously treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone/methotrexate, cytarabine (Hyper-CVAD) chemotherapyShan Yuan, Shirong Wang, Amandeep Salhotra, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|March 12, 2026
Overcoming resistance to immune checkpoint inhibitor therapy in acute myeloid leukemiaVaibhav Agrawal, Amandeep Salhotra
Cancer Treatment and Research|October 9, 2021
Acute Promyelocytic Leukemia: Update on Risk Stratification and Treatment PracticesAmandeep Salhotra, Matthew Mei
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 22, 2014
JAK2 (V617F) Positive Latent Myeloproliferative Neoplasm Presenting with Splanchnic Vein ThrombosisAmandeep Salhotra, Thein H Oo
Frontiers in Oncology|March 4, 2022
Role of Radiation Based Conditioning Regimens in Patients With High-Risk AML Undergoing Allogenic Transplantation in Remission or Active Disease and Mechanisms of Post-Transplant RelapseAmandeep Salhotra, Anthony Selwyn Stein
Cureus|January 10, 2022
Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic LeukemiaColton Ladbury, Amandeep Salhotra, Savita Dandapani
Journal of Intensive Care Medicine|August 7, 2024
Graft Versus Host Disease: Management Issues in the Intensive Care UnitAmandeep Salhotra, Dat Ngo, Waasil Kareem
Frontiers in Oncology|September 13, 2023
Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantationAmandeep Salhotra, Shan Yuan, Haris Ali
Expert Review of Clinical Immunology|March 11, 2020
Ruxolitinib for the treatment of graft-versus-host diseaseHaris Ali, Amandeep Salhotra, Badri Modi, et al.
Acta Haematologica|September 14, 2023
Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia PatientsJose Tinajero, Dat Ngo, Amandeep Salhotra, et al.
Leukemia & Lymphoma|September 27, 2013
Plerixafor to the rescue: boosting peripheral blood stem cell mobilization in patients previously treated with hyperfractionated cyclophosphamide, vincristine, doxorubicin, dexamethasone/methotrexate, cytarabine (Hyper-CVAD) chemotherapyShan Yuan, Shirong Wang, Amandeep Salhotra, et al.
Pageof 13